169 related articles for article (PubMed ID: 34930873)
1. The Role of Artificial Intelligence in the Diagnosis and Management of Glaucoma.
Ittoop SM; Jaccard N; Lanouette G; Kahook MY
J Glaucoma; 2022 Mar; 31(3):137-146. PubMed ID: 34930873
[TBL] [Abstract][Full Text] [Related]
2. The Definition of Glaucomatous Optic Neuropathy in Artificial Intelligence Research and Clinical Applications.
Medeiros FA; Lee T; Jammal AA; Al-Aswad LA; Eydelman MB; Schuman JS; ;
Ophthalmol Glaucoma; 2023; 6(4):432-438. PubMed ID: 36731747
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning in the Detection of the Glaucomatous Disc and Visual Field.
Smits DJ; Elze T; Wang H; Pasquale LR
Semin Ophthalmol; 2019; 34(4):232-242. PubMed ID: 31132292
[TBL] [Abstract][Full Text] [Related]
4. Progression of patterns (POP): a machine classifier algorithm to identify glaucoma progression in visual fields.
Goldbaum MH; Lee I; Jang G; Balasubramanian M; Sample PA; Weinreb RN; Liebmann JM; Girkin CA; Anderson DR; Zangwill LM; Fredette MJ; Jung TP; Medeiros FA; Bowd C
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6557-67. PubMed ID: 22786913
[TBL] [Abstract][Full Text] [Related]
5. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
6. Glaucoma management in the era of artificial intelligence.
Devalla SK; Liang Z; Pham TH; Boote C; Strouthidis NG; Thiery AH; Girard MJA
Br J Ophthalmol; 2020 Mar; 104(3):301-311. PubMed ID: 31640973
[TBL] [Abstract][Full Text] [Related]
7. Combining structural and functional testing for detection of glaucoma.
Shah NN; Bowd C; Medeiros FA; Weinreb RN; Sample PA; Hoffmann EM; Zangwill LM
Ophthalmology; 2006 Sep; 113(9):1593-602. PubMed ID: 16949444
[TBL] [Abstract][Full Text] [Related]
8. The role of clinical examination of the optic nerve head in glaucoma today.
Sihota R; Sidhu T; Dada T
Curr Opin Ophthalmol; 2021 Mar; 32(2):83-91. PubMed ID: 33470671
[TBL] [Abstract][Full Text] [Related]
9. [Artificial intelligence and glaucoma: A literature review].
Bunod R; Augstburger E; Brasnu E; Labbe A; Baudouin C
J Fr Ophtalmol; 2022 Feb; 45(2):216-232. PubMed ID: 34991909
[TBL] [Abstract][Full Text] [Related]
10. Prediction of visual field progression in glaucoma: existing methods and artificial intelligence.
Asaoka R; Murata H
Jpn J Ophthalmol; 2023 Sep; 67(5):546-559. PubMed ID: 37540325
[TBL] [Abstract][Full Text] [Related]
11. Monitoring Glaucomatous Functional Loss Using an Artificial Intelligence-Enabled Dashboard.
Yousefi S; Elze T; Pasquale LR; Saeedi O; Wang M; Shen LQ; Wellik SR; De Moraes CG; Myers JS; Boland MV
Ophthalmology; 2020 Sep; 127(9):1170-1178. PubMed ID: 32317176
[TBL] [Abstract][Full Text] [Related]
12. Glaucoma Mimickers: A major review of causes, diagnostic evaluation, and recommendations.
Senthil S; Nakka M; Sachdeva V; Goyal S; Sahoo N; Choudhari N
Semin Ophthalmol; 2021 Nov; 36(8):692-712. PubMed ID: 33689583
[No Abstract] [Full Text] [Related]
13. Assessing visual field clustering schemes using machine learning classifiers in standard perimetry.
Boden C; Chan K; Sample PA; Hao J; Lee TW; Zangwill LM; Weinreb RN; Goldbaum MH
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5582-90. PubMed ID: 18055807
[TBL] [Abstract][Full Text] [Related]
14. Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice.
Mursch-Edlmayr AS; Ng WS; Diniz-Filho A; Sousa DC; Arnold L; Schlenker MB; Duenas-Angeles K; Keane PA; Crowston JG; Jayaram H
Transl Vis Sci Technol; 2020 Oct; 9(2):55. PubMed ID: 33117612
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device.
Prabhakar B; Singh RK; Yadav KS
Comput Med Imaging Graph; 2021 Jan; 87():101818. PubMed ID: 33307283
[TBL] [Abstract][Full Text] [Related]
16. [New insights into the pathogenesis of glaucomatous optic neuropathy and refinement of the objective assessment of its functional damage].
Nakamura M
Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):298-344; discussion 345-6. PubMed ID: 22568105
[TBL] [Abstract][Full Text] [Related]
17. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
[TBL] [Abstract][Full Text] [Related]
18. Improvement in structure and visual function in patients with glaucoma: the possible key to better treatment?
Ahmed OM; Waisbourd M; Spaeth GL; Katz LJ
Surv Ophthalmol; 2021; 66(4):644-652. PubMed ID: 33316283
[TBL] [Abstract][Full Text] [Related]
19. Measures of disease activity in glaucoma.
Wu Y; Szymanska M; Hu Y; Fazal MI; Jiang N; Yetisen AK; Cordeiro MF
Biosens Bioelectron; 2022 Jan; 196():113700. PubMed ID: 34653715
[TBL] [Abstract][Full Text] [Related]
20. Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy.
Pérez-Rico C; Gutiérrez-Díaz E; Mencía-Gutiérrez E; Díaz-de-Atauri MJ; Blanco R
Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1345-57. PubMed ID: 24859387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
